|
NXTC NextCure Inc 1661059 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-9,796,000.00 |
| Balance Sheet |
|
Current Assets
|
$31,741,000.00 |
|
Assets
|
$37,977,000.00 |
|
Current Liabilities
|
$6,891,000.00 |
|
Liabilities
|
$11,261,000.00 |
|
Equity
|
$26,716,000.00 |
|
Shares Out
|
3607555.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,363,000.00 |
|
Investing Cash Flow
|
$1,300,000.00 |
| Market Analysis |
Market Cap
|
$18,146,001.65 |
|
Price
|
$4.14 |
|
BVPS
|
7.41 |
|
PB
|
0.68 |
|
EPS
|
-1.87 |
|
FCF
|
$-13,837,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:46 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NXTC documents filed with the SEC.
NXTC Filings
Clear
